{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:05:21Z","timestamp":1780466721786,"version":"3.54.1"},"reference-count":41,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To investigate the reporting of harms in systematic reviews (SRs) focused on hallucinogen use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A search was conducted in May 2022 using MEDLINE, Embase, Epistemonikos, and Cochrane databases to retrieve SRs focused on the use of hallucinogens. Investigators screened the titles and abstracts from the search for study inclusion in a masked, triplicate fashion. Investigators analyzed the included SRs for reported harms linked to hallucinogen use via a pre-established harms reporting assessment. Methodological quality of SRs was graded using the A MeaSurement Tool to Assess Systematic Reviews-2 (AMSTAR-2) in a masked, duplicate manner. Study characteristics for each review were extracted in duplicate. The corrected covered area was measured for SR dyads.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Our search returned 908 articles, and 32 SRs met eligibility criteria for final harms reporting analysis. Of the included reviews, 28 SRs (56.2%) indicated harms as a primary or secondary outcome, 2 SRs (6.3%) reported predetermined methods to grade, collect harms data, or statistically analyze harms. A significant relationship was found between completeness of harm reporting and whether harms were listed as a primary or secondary outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Harms were largely underreported in scientific literature regarding hallucinogen use, despite many studies designating them as a primary or secondary outcome. Inadequate reporting is unlikely to provide credible evidence used to evaluate the benefit-harm trade-off. Therefore, steps should be taken to improve the reporting of harms in studies concerning hallucinogen use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02698811251399554","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T10:03:01Z","timestamp":1766743381000},"page":"316-324","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of the reporting of harms in systematic reviews focused on hallucinogens: A cross-sectional study"],"prefix":"10.1177","volume":"40","author":[{"given":"Kaylin","family":"Ray","sequence":"first","affiliation":[{"name":"Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1123-0237","authenticated-orcid":false,"given":"Kaylyn Jade","family":"Rowsey","sequence":"additional","affiliation":[{"name":"Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Kramer","sequence":"additional","affiliation":[{"name":"Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah","family":"Kee","sequence":"additional","affiliation":[{"name":"Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Flores","sequence":"additional","affiliation":[{"name":"Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Wise","sequence":"additional","affiliation":[{"name":"Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Garrett","sequence":"additional","affiliation":[{"name":"Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brayden","family":"Rucker","sequence":"additional","affiliation":[{"name":"Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Newhardt","sequence":"additional","affiliation":[{"name":"Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Beaman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Vassar","sequence":"additional","affiliation":[{"name":"Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA"},{"name":"Department of Psychiatry and Behavioral Sciences, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"e_1_3_3_2_1","unstructured":"AMSTAR (n.d.) Assessing the Methodological Quality of Systematic Reviews. Available at: https:\/\/amstar.ca\/ (accessed 1 June 2022)."},{"key":"e_1_3_3_3_1","unstructured":"AMSTAR-2 (2018) Spotlight on Methods and Tools. Available at: https:\/\/www.youtube.com\/watch?v=gdbIFo7FCVE (accessed 1 June 2022)."},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2019-111233"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2019.109735"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpp.13898"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2024.08.091"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002187"},{"key":"e_1_3_3_9_1","unstructured":"Coursera (n.d.) Introduction to Systematic Review and Meta-Analysis. Available at: https:\/\/www.coursera.org\/learn\/systematic-review (accessed 22 February 2022)."},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/anae.13520"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2018.1511424"},{"key":"e_1_3_3_12_1","doi-asserted-by":"crossref","unstructured":"Golder S Loke YK Wright K et al. (2016) Reporting of adverse events in published and unpublished studies of health care interventions: A systematic review. PLoS Medicine 13(9): e1002127.","DOI":"10.1371\/journal.pmed.1002127"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00414-025-03439-9"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-017-1870-2"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1390"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-016-1327-z"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2021.08.016"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01706-7"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpp.1765"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2014.06.016"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-1341-1907"},{"key":"e_1_3_3_22_1","volume-title":"The ASAM Principles of Addiction Medicine","author":"Miller S","year":"2018","unstructured":"Miller S (2018) The ASAM Principles of Addiction Medicine. Lippincott Williams & Wilkins."},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535"},{"key":"e_1_3_3_24_1","unstructured":"National Institute on Drug Abuse (2019) Hallucinogens DrugFacts. Available at: https:\/\/nida.nih.gov\/publications\/drugfacts\/hallucinogens (accessed 22 June 2022)."},{"key":"e_1_3_3_25_1","unstructured":"OSF (n.d.). Psychedelics. Available at: https:\/\/osf.io\/49smk\/ (accessed 24 June 2022)."},{"key":"e_1_3_3_26_1","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. (2021) The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 372: n71.","journal-title":"BMJ"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2018.12.007"},{"key":"e_1_3_3_28_1","article-title":"Celecoxib for osteoarthritis","volume":"5","author":"Puljak L","year":"2017","unstructured":"Puljak L, Marin A, Vrdoljak D, et al. (2017) Celecoxib for osteoarthritis. Cochrane Database of Systematic Reviews 5: CD009865.","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2021.10.023"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2021.10.025"},{"key":"e_1_3_3_31_1","doi-asserted-by":"crossref","unstructured":"Qureshi R Mayo-Wilson E Rittiphairoj T et al. (2021b) Summaries of harms in systematic reviews are unreliable (Part 1 of 2): Methods used to assess harms are neglected in systematic reviews of gabapentin. Available at: http:\/\/doi.org\/10.31219\/osf.io\/7g4ez (accessed 24 June 2022).","DOI":"10.31219\/osf.io\/7g4ez"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2019.19010035"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881120919957"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211069100"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2017.06.010"},{"key":"e_1_3_3_36_1","article-title":"Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports","volume":"352","author":"Sharma T","year":"2016","unstructured":"Sharma T, Guski LS, Freund N, et al. (2016) Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports. BMJ 352: i65.","journal-title":"BMJ"},{"key":"e_1_3_3_37_1","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea BJ","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, et al. (2017) AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ 358: j4008.","journal-title":"BMJ"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1995"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2017.1320734"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6882-11-67"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f7668"},{"key":"e_1_3_3_42_1","article-title":"PRISMA harms checklist: improving harms reporting in systematic reviews","volume":"352","author":"Zorzela L","year":"2016","unstructured":"Zorzela L, Loke YK, Ioannidis JP, et al. (2016) PRISMA harms checklist: improving harms reporting in systematic reviews. BMJ 352: i157.","journal-title":"BMJ"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811251399554","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02698811251399554","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811251399554","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:18:19Z","timestamp":1780463899000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02698811251399554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1177\/02698811251399554"],"URL":"https:\/\/doi.org\/10.1177\/02698811251399554","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]}}}